Ceryvyn Therapeutics Ltd
OPT
Clasificación en acciones
#31862
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Precio por acción
$0.00846342
Última sincronización: 2026-07-27
Capitalización bursátil
$11.27M
Cambio (1 día)
0.00%
Cambio (1 año)
-99.75%
País
AU
Comercio Ceryvyn Therapeutics Ltd (OPT)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Ceryvyn Therapeutics Ltd (OPT)
La acción Ceryvyn Therapeutics Ltd (símbolo: OPT) tuvo un total de 2 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 16, 2020.
Una acción OPT comprada antes de Sep 13, 2016 equivaldría hoy a 0.638125 acciones OPT.
El desdoblamiento más reciente ocurrió el Oct 16, 2020.
Una acción OPT comprada antes de Sep 13, 2016 equivaldría hoy a 0.638125 acciones OPT.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2020-10-16 | 5:8 | x0.625 | x0.638125 |
| 2016-09-13 | 1021:1000 | x1.021 | x1.021 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
